Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,129 JPY | +1.45% | +0.10% | +1.85% |
03:39am | Takeda Pharmaceutical's Attributable Profit Falls 55% in Fiscal 2024 | MT |
09/05 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
Sales 2024 | 4,264B 27.38B 2,284B | Sales 2025 * | 4,058B 26.06B 2,174B | Capitalization | 6,386B 41.01B 3,421B |
---|---|---|---|---|---|
Net income 2024 | 144B 925M 77.19B | Net income 2025 * | 156B 1B 83.64B | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.22B 2,020B | Net Debt 2025 * | 3,994B 25.65B 2,140B | EV / Sales 2025 * | 2.57 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
39.3
x | Employees | 49,095 |
Yield 2024 * |
4.55% | Yield 2025 * |
4.6% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | +1.45% | ||
1 week | +0.10% | ||
Current month | -0.58% | ||
1 month | -0.89% | ||
3 months | -3.05% | ||
6 months | -0.67% | ||
Current year | +1.85% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 01/14/01 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/22/01 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 01/16/01 | |
Ian Clark
BRD | Director/Board Member | 62 | 01/19/01 |
Steven Gillis
BRD | Director/Board Member | 71 | 01/19/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
24.44% | 0 M€ | +11.43% | ||
5.00% | 0 M€ | +23.89% | ||
3.80% | 0 M€ | +20.85% | ||
3.43% | 0 M€ | +13.17% | ||
3.26% | 0 M€ | +20.78% |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 4,129 | +1.45% | 8 275 700 |
09/24/09 | 4,070 | +0.42% | 3,465,100 |
08/24/08 | 4,053 | -1.12% | 5,332,100 |
07/24/07 | 4,099 | -0.63% | 6,576,000 |
02/24/02 | 4,125 | -0.43% | 3,157,000 |
Delayed Quote Japan Exchange, May 10, 2024 at 11:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.85% | 41.03B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+17.12% | 239B | |
+8.06% | 204B | |
-7.61% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- 4502 Stock